Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of Parkinson's disease

Neurotoxicology. 2019 Jul:73:132-141. doi: 10.1016/j.neuro.2019.03.005. Epub 2019 Mar 28.

Abstract

Parkinson's disease is the most prevalent movement disorder. Currently, therapies are palliative with associated irreversible behavioural incompetence. Here, we investigated the ability of kolaviron (KV), an anti-inflammatory biflavonoid isolated form Garcinia kola seeds, to rescue striatal neuronal damage and redo-inflammation in rats exposed to rotenone (ROT). Aged rats exposed to 11 days of rotenone intoxication were treated with KV either concurrently or for 18 days. The 18-day regimen included 7 days of pre-treatment prior 11-day concurrent ROT-KV treatment. Rotenone-exposed rats lost weight appreciably and travelled less distance with reduced speed, decline efficiency to maintain a straight path, enhanced freezing, increased immobile episodes and poor hole recognition. The motor incompetence was attributed to enhanced striatal neurodegeneration, increased alpha synuclein formation and reduced tyrosine hydroxylase expression. ROT intoxication significantly increased reactive species production, which co-existed with induction of striatal antioxidant system and damage to biomolecules. ROT additionally upregulated COX-2 expression, enhanced myeloperoxidase activity and increased concentration of striatal inteleukine-6 (IL-6), IL-1β and tumour necrosis factor (TNF-α). Treatment with kolaviron reversed the rotenone-associated locomotor impairment and exploratory deficits, motor/neuromuscular incompetence, striatal neurodegeneration, neurobiochemical imbalance, altered antioxidant defence system and neuroinflammation. KV-treated rats showed improved capacity to maintain efficient gait with minimal rigidity and enhanced coordination. Taken together, kolaviron exhibited neuroprotective properties, which may be beneficial for the prevention and management of Parkinson's disease, via antioxidant, anti-inflammatory and anti-apoptotic mechanisms.

Keywords: Kolaviron; Neurobehavioural deficits; Rotenone; Striatal redo-inflammation; Tyrosine hydroxylase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Antiparkinson Agents / pharmacology*
  • Apoptosis / drug effects
  • Behavior, Animal / drug effects
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Corpus Striatum / pathology
  • Corpus Striatum / physiopathology
  • Cytokines / metabolism
  • Disease Models, Animal
  • Exploratory Behavior / drug effects
  • Flavonoids / pharmacology*
  • Inflammation Mediators / metabolism
  • Locomotion / drug effects
  • Male
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neurons / pathology
  • Neuroprotective Agents / pharmacology*
  • Oxidative Stress / drug effects
  • Parkinsonian Disorders / chemically induced
  • Parkinsonian Disorders / drug therapy*
  • Parkinsonian Disorders / metabolism
  • Parkinsonian Disorders / pathology
  • Rats, Wistar
  • Reactive Oxygen Species / metabolism
  • Rotenone*
  • Tyrosine 3-Monooxygenase / metabolism
  • alpha-Synuclein / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antiparkinson Agents
  • Cytokines
  • Flavonoids
  • Inflammation Mediators
  • Neuroprotective Agents
  • Reactive Oxygen Species
  • alpha-Synuclein
  • Rotenone
  • Tyrosine 3-Monooxygenase
  • kolaviron